Cargando…
Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis
Hyperglycemia-induced renal fibrosis causes end-stage renal disease. Clopidogrel, a platelet inhibitor, is often administered to decrease cardiovascular events in diabetic patients. We investigated whether clopidogrel can reduce diabetes-induced renal fibrosis in a streptozotocin-induced type 1 diab...
Autores principales: | Zheng, Zongyu, Ma, Tianjiao, Lian, Xin, Gao, Jialin, Wang, Weigang, Weng, Wenya, Lu, Xuemian, Sun, Weixia, Cheng, Yanli, Fu, Yaowen, Rane, Madhavi J., Gozal, Evelyne, Cai, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329922/ https://www.ncbi.nlm.nih.gov/pubmed/30662363 http://dx.doi.org/10.7150/ijbs.29063 |
Ejemplares similares
-
Diabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic Inflammation
por: Jagadapillai, Rekha, et al.
Publicado: (2016) -
Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
por: Weng, Wenya, et al.
Publicado: (2020) -
The role of FGF21 in type 1 diabetes and its complications
por: Zhang, Jian, et al.
Publicado: (2018) -
Inhibition of fibronectin accumulation suppresses TUMOR growth
por: Ghura, Hiba, et al.
Publicado: (2021) -
Cytotoxic secondary metabolites isolated from Penicillium sp. YT2019-3321, an endophytic fungus derived from Lonicera Japonica
por: Weng, Wenya, et al.
Publicado: (2022)